Kathleen Van Dyk

About Kathleen Van Dyk

Kathleen Van Dyk, With an exceptional h-index of 19 and a recent h-index of 16 (since 2020), a distinguished researcher at University of California, Los Angeles, specializes in the field of cancer-related cognitive impairment, cancer survivorship, cognitive rehabilitation, dementia, Alzheimer's Disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study

Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study

Assessing cancer-related cognitive function in the context of everyday life using ecological mobile cognitive testing: A protocol for a prospective quantitative study

Validating the PROMIS cognitive function short form in cancer survivors

Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study

Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors: the thinking and living with cancer study

CanCOG®: Cultural Adaptation of the Evidence-Based UCLA Cognitive Rehabilitation Intervention Program for Cancer Survivors in Portugal

Behavioral and transcriptomic effects of the cancer treatment Tamoxifen in mice

Kathleen Van Dyk Information

University

Position

Semel Institute & Jonsson Comprehensive Cancer Center

Citations(all)

1212

Citations(since 2020)

921

Cited By

545

hIndex(all)

19

hIndex(since 2020)

16

i10Index(all)

29

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Kathleen Van Dyk Skills & Research Interests

cancer-related cognitive impairment

cancer survivorship

cognitive rehabilitation

dementia

Alzheimer's Disease

Top articles of Kathleen Van Dyk

Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study

JNCI Cancer Spectrum

2024/4/1

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study

Cancer

2023/9/1

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Assessing cancer-related cognitive function in the context of everyday life using ecological mobile cognitive testing: A protocol for a prospective quantitative study

Digital Health

2023/8

Validating the PROMIS cognitive function short form in cancer survivors

Breast cancer research and treatment

2023/8

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study

Cancer

2023/8/1

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Elevated C-reactive protein and subsequent patient-reported cognitive problems in older breast cancer survivors: the thinking and living with cancer study

Journal of Clinical Oncology

2023/1/10

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

CanCOG®: Cultural Adaptation of the Evidence-Based UCLA Cognitive Rehabilitation Intervention Program for Cancer Survivors in Portugal

Healthcare

2023/1/2

Behavioral and transcriptomic effects of the cancer treatment Tamoxifen in mice

Frontiers in Neuroscience

2023/2/10

Harshul Pandit
Harshul Pandit

H-Index: 7

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Abstract B111: Black-White differences in physical and cognitive aging among older breast cancer survivors in the Thinking and Living with Cancer Study

2023/1/1

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study

Journal of Cancer Survivorship

2023/11/4

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

17 Comparing Cognitive Patient-Reported Outcomes with Neuropsychological Impairment in Patients with Diffuse Glioma.

Journal of the International Neuropsychological Society

2023/11

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

53 Healthcare Quality, Race, and Neuropsychological Functioning in Black/African-American Individuals with HIV

Journal of the International Neuropsychological Society

2023/11

Maral Aghvinian
Maral Aghvinian

H-Index: 5

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group (vol 113, pg 1625, 2021)

JNCI: Journal of the National Cancer Institute

2021/12/1

QOL-12.“I’M JUST LIKE A BASKET FULL OF PROBLEMS”: QUALITATIVE STUDY OF COGNITIVE DYSFUNCTION AND QUALITY OF LIFE IN GLIOMA SURVIVORS

Neuro-oncology

2022/11

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Timothy Cloughesy
Timothy Cloughesy

H-Index: 78

Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer …

Journal of geriatric oncology

2022/11/1

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID‐19 virus pandemic among older women with and without breast …

Cancer medicine

2022/9

Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: the Thinking and Living with Cancer Study

Breast cancer research and treatment

2022/7

Jaeil Ahn
Jaeil Ahn

H-Index: 19

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Multimodal MRI examination of structural and functional brain changes in older women with breast cancer in the first year of antiestrogen hormonal therapy

Breast cancer research and treatment

2022/7

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

HIV antiretroviral medication neuropenetrance and neurocognitive outcomes in HIV+ adults: a review of the literature examining the central nervous system penetration …

Viruses

2022

Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation Networks

Tomography

2022/5/26

Kathleen Van Dyk
Kathleen Van Dyk

H-Index: 11

Noriko Salamon
Noriko Salamon

H-Index: 35

See List of Professors in Kathleen Van Dyk University(University of California, Los Angeles)